Polymarket$3.18BOIOpen interest: sum of pool liquidity across all active markets, reported by the Polymarket API.
Kalshi$401.77MOIOpen interest: total contracts outstanding across all active markets, reported by the Kalshi API.
Limitless$25.30MOIOpen interest: estimated from total volume traded (USDC). Limitless does not report a separate OI metric.
Updated Today
If the FDA approves a cure for Type 1 diabetes before Jan 1, 2033, then the market resolves to Yes.
As of March 18, 2026, the Kalshi odds for Will the FDA approve a cure for Type 1 Diabetes before 2033? are: Before 2033: 35%. These probabilities are derived from real-money trading and update in real time.
Will the FDA approve a cure for Type 1 Diabetes before 2033? is currently available on Kalshi. Check PredictMarketCap for cross-platform availability as new markets are added regularly.
Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.
